• #927964
  • 314
  • Merck #00006409502

Vaqta® Hepatitis A Vaccine Pediatric / Adolescent, 12 Months Through 18 Years of Age 25 Unit / 0.5 mL Injection Prefilled Syringe 0.5 mL

VAQTA, SYR PED 25U/0.5ML (10/BX)

Features
  • VAQTA® [Hepatitis A Vaccine, Inactivated] is indicated for the prevention of disease caused by hepatitis A virus (HAV) in persons 12 months of age and older
  • VAQTA is a sterile suspension for intramuscular injection
  • One milliliter of the vaccine contains approximately 50U of hepatitis A virus antigen, which is purified and formulated without a preservative
  • More …
  Log In to Order
or

Product Specifications


Features
  • VAQTA® [Hepatitis A Vaccine, Inactivated] is indicated for the prevention of disease caused by hepatitis A virus (HAV) in persons 12 months of age and older
  • VAQTA is a sterile suspension for intramuscular injection
  • One milliliter of the vaccine contains approximately 50U of hepatitis A virus antigen, which is purified and formulated without a preservative
  • Each 0.5-mL pediatric dose contains 25U of hepatitis A virus antigen and adsorbed onto approximately 0.225 mg of aluminum provided as amorphous aluminum hydroxy phosphate sulfate, and 35 mcg of sodium borate as a pH stabilizer, in 0.9% sodium chloride

Professionals Also Viewed